Skip to main content
Intermediate Technical In the Industry Vocabulary Test

tumor debulking

Surgical reduction of tumor burden when complete removal is not feasible, aimed at improving treatment response.

Full Definition

Tumor debulking, also known as cytoreductive surgery, involves the surgical removal of as much tumor tissue as possible when complete resection cannot be achieved. This palliative approach is commonly employed in ovarian cancer, peritoneal carcinomatosis, and other advanced malignancies where the goal is to reduce tumor burden to enhance the effectiveness of subsequent chemotherapy or radiation therapy. The degree of debulking is often classified as optimal (residual disease ≤1 cm) or suboptimal (residual disease >1 cm). While not curative, aggressive debulking can significantly improve patient survival and quality of life in appropriately selected cases.

Usage

Usage note: Use 'debulking' as one word, not 'de-bulking'. Often preceded by qualifiers like 'optimal' or 'suboptimal'.

In Context

  • "Optimal tumor debulking was achieved with residual disease measuring less than 0.5 cm." — Operative report
  • "The patient underwent extensive tumor debulking followed by heated intraperitoneal chemotherapy." — Treatment plan

Also known as

cytoreductive surgery tumor reduction

Contrasted with

curative resection en bloc resection

Don't confuse with

palliative surgery tumor biopsy

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON